Last reviewed · How we verify
NCT05703191
A Real-world Study of Nitric Oxide Generator and Delivery System
trial testing Nitric Oxide Generator and Delivery System in Pulmonary Hypertension of Newborn in 10 participants. Currently enrolling.
31 March 2025
Quick facts
| Lead sponsor | Novlead Inc. |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 10 |
| Start date | 3 February 2023 |
| Primary completion | 31 March 2025 |
| Estimated completion | 31 May 2025 |
| Sites | 1 location across China |
Drugs / interventions tested
- Nitric Oxide Generator and Delivery System
Conditions studied
- Pulmonary Hypertension of Newborn — all drugs for Pulmonary Hypertension of Newborn →
Sponsor
Novlead Inc.
Who can join
Eligibility, any sex, with Pulmonary Hypertension of Newborn. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study is aimed to observe the efficacy and safety of Nitric Oxide Generator and Delivery System in Pulmonary Hypertension of Newborn in real clinical settings.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05703191
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Novlead Inc. trials
Trials by the same sponsor.
- NCT06852911 — FeNO Detection in Asthma Diagnosis: A New Technology Approach · NA · recruiting
- NCT06852924 — Inhaled Nitric Oxide for High Amplitude Pulmonary Edema (HAPE) · NA · recruiting
- NCT07382258 — A Clinical Study of Inhaled Nitric Oxide in Patients With Chronic Obstructive Pulmonary Disease · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05703191 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Novlead Inc.
- Last refreshed: 19 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05703191.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing